Dihydromyricetin Alleviates Non-Alcoholic Fatty Liver Disease by Modulating Gut Microbiota and Inflammatory Signaling PathwaysLi-min Kang, Lang Li|Journal of Microbiology and Biotechnology|2024Cited by 12